Bio

John joined GTCR in 2006 and became a Principal in the Healthcare group in 2017. Prior to joining GTCR, he worked as an Analyst in the Healthcare investment banking group of Citigroup Global Markets in New York. John holds an MBA with distinction from Harvard Business School and a BS in finance with highest honors from the University of Illinois. He currently serves as a Director of Antylia Scientific, Cedar Gate Technologies and Transaction Data Systems and works closely with Water’s Edge/Riverchase Dermatology. He was previously involved in past GTCR investments CCS, Cole-Parmer, GreatCall and XIFIN.